MENU
TBXU
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

TBXU stock forecast, quote, news & analysis

The investment seeks daily investment results, before fees and expenses, of 200% of the daily performance of the NYSE Biotechnology Index... Show more

Category: #Trading
TBXU
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for TBXU with price predictions
Aug 13, 2026

Momentum Indicator for TBXU turns positive, indicating new upward trend

TBXU saw its Momentum Indicator move above the 0 level on July 24, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 12 similar instances where the indicator turned positive. In of the 12 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for TBXU just turned positive on July 28, 2026. Looking at past instances where TBXU's MACD turned positive, the stock continued to rise in of 7 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TBXU advanced for three days, in of 34 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 30 cases where TBXU Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 14 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TBXU declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TBXU broke above its upper Bollinger Band on August 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN).

Industry description

The investment seeks daily investment results, before fees and expenses, of 200% of the daily performance of the NYSE Biotechnology Index. The fund, under normal circumstances, invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments, such as swap agreements, securities of the index, and exchange-traded funds ("ETFs") that track the index, that, in combination, provide 2X daily leveraged exposure to the index, consistent with the fund's investment objective. The components of the index and the percentages represented by various sectors in the index may change over time. The fund is non-diversified.

Market Cap

The average market capitalization across the Direxion Daily Biotech Top 5 Bull 2X ETF ETF is 133.12B. The market cap for tickers in the group ranges from 54.4B to 226.05B. AMGN holds the highest valuation in this group at 226.05B. The lowest valued company is ARGX at 54.4B.

High and low price notable news

The average weekly price growth across all stocks in the Direxion Daily Biotech Top 5 Bull 2X ETF ETF was 3%. For the same ETF, the average monthly price growth was 21%, and the average quarterly price growth was 13%. VRTX experienced the highest price growth at 7%, while ARGX experienced the biggest fall at -2%.

Volume

The average weekly volume growth across all stocks in the Direxion Daily Biotech Top 5 Bull 2X ETF ETF was -38%. For the same stocks of the ETF, the average monthly volume growth was -11% and the average quarterly volume growth was -67%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 37
P/E Growth Rating: 45
Price Growth Rating: 35
SMR Rating: 35
Profit Risk Rating: 30
Seasonality Score: -1 (-100 ... +100)
View a ticker or compare two or three
TBXU
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Details
Category
Trading--Leveraged Equity
Address
Direxion Shares ETF Trust33 Whitehall Street,10th FloorNew York
Phone
866-476-7523
Web
http://www.direxioninvestments.com/
Momentum Indicator for TBXU turns positive, indicating new upward trend